Subscribe now to the Silphium Pharmaceutical Company newsletter.
- Saturday - Thursday, 08:00 AM - 05:00 PM
- 0910685333
Silphium Company for Pharmaceutical Industries and Preparations adopts a sound corporate governance policy to serve as a role model through:
Specialized committees such as:
Internal Audit Committee.
Risk Committee.
Sharia Compliance Committee (Sharia Supervisory Board in coordination with an independent body).
Commitment to preparing periodic financial and operational reports for investors.
Disclosure of distributions, performance, and material risks.
Publishing annual reports including Sharia and accounting observations.
Appointing an independent external auditor.
Activating an effective internal audit system that reports to the audit committee.
Silphium Company adopts written policies that are submitted to the Board of Directors, covering:
Operational risks.
Market risks.
Sharia compliance risks.
Presence of an emergency response plan and periodic risk assessmen
An independent Sharia Supervisory Board exists.
All contracts and financing structures must be approved by the Board before implementation.
Issuing a periodic Sharia report on the compliance of the company’s activities with Sharia provisions.
Ensuring investors’ access to information.
Establishing mechanisms for dispute resolution (through the Commercial Arbitration Center).
Representation of sukuk holders through an agent or a follow-up committee.
The leading company in the pharmaceutical and medical products industry in Libya.
All rights reserved © Designed by Qeematech